Acyclovir, known as the brand name Xerese, is an efficacious medication used to treat herpes labialis. Known commonly as cold sores or fever blisters, this form of the herpes virus is successfully treated with Acyclovir as a combination cream, alongside hydrocortisone. Marketed by Coria Laboratories, the patent for Xerese expires on January 24, 2017. The[…]
Acyclovir Successfully Halts the Spread of Herpes
Anti-Retroviral / Anti-HIV, Antiviral, Bulk Active Ingredient, Drug Research & Development API, Patent Expiration 2017, TEVA API Jan 17, 2013
Acetaminophen is a Powerful Post-Surgical Pain Treatment
Analgesic, Patent Expiration 2017 Jan 11, 2013
As a widely used analgesic for upwards of 30 years, Acetaminophen is safe for both children and adults as a treatment for fever and pain. With an expiration of the brand name Ofirmev on August 5, 2017, generic possibilities abound for this unique injectable medication. The recent concern among doctors and patients regarding opioid dependence[…]
Prasugrel Is Key to Successful Angioplasties
Antithrombotic, Blood Product, Drug Research & Development API, FDA Approved 2009, Patent Expiration 2017 Tags: percutaneous coronary interventionPlavix Nov 20, 2012
Known as the brand name Effient, Prasugrel was approved by the FDA in July of 2009 as a blood thinning drug. Designed to be used to reduce the risk of blood clots from forming in patients who undergo angioplasty, which is a common procedure to unblock a clogged coronary artery, Prasugrel was studied in close[…]